grant

Integrin beta3 as a therapeutic target for breast cancer metastasis to bone [ 2008 - 2010 ]

Also known as: Inhibiting tumour cell attachment in breast cancer spread to bone

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/509131]

Researchers: Dr Normand Pouliot (Principal investigator) ,  Prof Robin Anderson

Brief description There are limited effective treatments for advanced breast cancer. The project investigates the role of a protein called integrin beta3 in the spread of breast tumours to bone, the most common site of secondary tumour formation (metastasis) in breast cancer patients. We will determine if the presence of integrin beta3 in breast tumours identifies patients at risk of developing bone metastases and test novel drugs against integrin beta3 in mice.

Funding Amount $AUD 431,675.71

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]